Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Leukemia|February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Talha Badar, Ehab Atallah, Rory Shallis, et al.
The ISME Journal|March 25, 2011
Marine bacterial, archaeal and protistan association networks reveal ecological linkagesJoshua A Steele, Peter D Countway, Li Xia, et al.
Cell Systems|November 13, 2025
Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biasesMaria Chernigovskaya, Khang Lê Quý, Maria Stensland, et al.
American Journal of Hematology|September 10, 2024
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional studyTalha Badar, Ravi Narra, Alice S Mims, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Microbiology Spectrum|February 11, 2025
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assaysMaria D Iglesias-Ussel, Aleah Bowie, Jack G Anderson, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Gastrointestinal Endoscopy|September 23, 2019
EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video)Somashekar G Krishna, Phil A Hart, John M DeWitt, et al.
Pageof 13